SAZ.DE : Summary for STADA ARZNEIMITT.VNA O.N. - Yahoo Finance

U.S. Markets closed

Stada-Arzneimittel AG (SAZ.DE)


XETRA - XETRA Delayed Price. Currency in EUR
Add to watchlist
44.31+0.03 (+0.07%)
At close: 11:35 AM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close44.28
Open44.99
Bid0.00 x 5000
Ask0.00 x 28500
Day's Range43.94 - 45.00
52 Week Range28.05 - 51.06
Volume485,071
Avg. Volume231,217
Market Cap2.77B
BetaN/A
PE Ratio (TTM)22.87
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • STADA Arzneimittel AG breached its 50 day moving average in a Bearish Manner : SAZ-DE : October 10, 2016
    Capital Cube2 months ago

    STADA Arzneimittel AG breached its 50 day moving average in a Bearish Manner : SAZ-DE : October 10, 2016

    Categories: Europe Stock Alerts Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for STADA Arzneimittel AG. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more (Read more...)

  • The Wall Street Journal3 months ago

    The Morning Risk Report: Shareholder Activism Set for Record Year in Europe

    Shareholder activism is on track to reach a new high in Europe this year, with events such as the U.K.’s vote to leave the European Union offering greater opportunity for investors looking to push for ...

  • STADA Arzneimittel AG – Value Analysis (XETRA:SAZ) : September 16, 2016
    Capital Cube3 months ago

    STADA Arzneimittel AG – Value Analysis (XETRA:SAZ) : September 16, 2016

    Categories: Europe Value Analsysis Yahoo Finance Click here to see latest analysis Capitalcube gives STADA Arzneimittel AG a score of 47. Our analysis is based on comparing STADA Arzneimittel AG with the following peers – Biotest AG Pref, Merck KGaA, Chemical Works of Gedeon Richter Plc, Bayer AG and MorphoSys AG (BIO3-DE, MRK-DE, RIG2-DE, BAYN-DE and MOR-DE). Investment Outlook STADA Arzneimittel ... Read more (Read more...)